Pathstone Family Office’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$99.9K Sell
18,327
-831
-4% -$6.66K ﹤0.01% 1586
2023
Q2
$176K Sell
19,158
-5,844
-23% -$49.4K ﹤0.01% 1159
2023
Q1
$208K Sell
25,002
-24,064
-49% -$266K ﹤0.01% 1073
2022
Q4
$525K Buy
49,066
+16,247
+50% +$189K ﹤0.01% 1072
2022
Q3
$389K Buy
+32,819
New +$497K ﹤0.01% 1165
2021
Q1
Sell
-857
Closed -$19K 1078
2020
Q4
$19K Hold
857
﹤0.01% 709
2020
Q3
$15K Buy
+857
New +$15.9K ﹤0.01% 537
2020
Q2
Sell
-1,161
Closed -$20K 879
2020
Q1
$20K Buy
+1,161
New +$24.3K ﹤0.01% 416

Other funds holding MPT

Pathstone Family Office's MPT Position: Q3 2023 in Review

Pathstone Family Office reduced its Medical Properties Trust (MPT) stake by 4.3% in Q3 2023, selling an estimated $6.66K and leaving 18,327 shares worth $99.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Pathstone Family Office first reported a position in MPT in Q1 2020 and has held it in 8 quarters since. The position peaked at $525K in Q4 2022. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • Pathstone Family Office held 18,327 shares of Medical Properties Trust worth $99.9K as of Q3 2023.
  • Pathstone Family Office sold 831 Medical Properties Trust shares in Q3 2023, an estimated $6.66K.
  • Medical Properties Trust made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1586 holding.
  • Pathstone Family Office first reported a position in Medical Properties Trust in Q1 2020 and has held it in 8 quarters since.
  • Pathstone Family Office's Medical Properties Trust position peaked at $525K in Q4 2022.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.